Fluoroleucine Alkyl Ester Synthesis via Chiral Resolution

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Asymmetric synthesis of γ-fluoro-α-amino acids, particularly the stereoselective incorporation of the γ-F-containing side chain, remains a challenge in the preparation of fluoroleucine alkyl esters, which are potential pharmaceutical agents, due to limitations in existing methods such as chiral auxiliary-directed diastereoselective alkylation and enzymatic hydrolysis.

Innovation Solution

A novel process involving the alkylation of an imine carboxylate with methallyl halide, followed by deprotection and resolution with chiral protic acids like D-(+)-camphor-10-sulfonic acid, in the presence of an aromatic aldehyde, and subsequent fluorination to yield fluoroleucine alkyl esters efficiently.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If chiral auxiliary-directed diastereoselective alkylation is used, then stereoselective incorporation of γ-F-containing side chain is achieved, but the process complexity and number of steps increase

Engineering Contradiction:
ImprovestereoselectivityVSAvoidprocess complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent employs chiral auxiliary-directed diastereoselective alkylation where a chiral auxiliary is attached to the amino acid precursor before the alkylation reaction. This preliminary action of attaching the chiral auxiliary creates a chiral environment that directs the stereoselective formation of the γ-fluoro side chain, achieving high stereoselectivity while managing process complexity through a well-established methodology

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The chiral auxiliary serves as an intermediary that temporarily modifies the substrate to enable diastereoselective alkylation. The auxiliary acts as a mediator that controls the stereochemistry of the reaction, allowing stereoselective incorporation of the γ-F-containing side chain while the auxiliary itself can be removed in subsequent steps

Inventive Principle:
Principle #24Intermediary (Mediator)

2Manufacturing precision

If enzymatic hydrolysis of suitable precursors is used, then stereoselective incorporation is achieved, but the scope and efficiency are limited

Engineering Contradiction:
ImprovestereoselectivityVSAvoidefficiency
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent replaces enzymatic methods with chemical catalysis approaches. Instead of using enzymes for stereoselective hydrolysis or transformation, the invention employs chiral phase transfer catalysts or organocatalysts that achieve similar or superior stereoselectivity through chemical mechanisms, thereby improving efficiency and broadening substrate scope beyond what enzymes can handle

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent modifies reaction parameters such as using phase transfer catalysis conditions, adjusting pH, temperature, and solvent systems to optimize both stereoselectivity and reaction efficiency. These parameter changes allow the chemical methods to compete with or surpass enzymatic methods in terms of productivity while maintaining high stereoselectivity

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If conventional resolution methods are used, then enantiomeric separation is achieved, but the throughput and cost-effectiveness decrease

Engineering Contradiction:
Improveenantiomeric purityVSAvoidthroughput
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent employs dynamic kinetic resolution where the chiral catalyst not only resolves the racemic mixture but also promotes racemization of the undesired enantiomer in situ. This self-service mechanism allows the system to continuously convert both enantiomers into the desired product form, achieving high throughput and enantiomeric purity without requiring separate resolution steps that would reduce productivity

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The resolution process is designed to be continuous rather than stepwise. The chiral catalyst maintains active resolution throughout the reaction, and the coupled racemization ensures that the useful action of enantiomer separation continues without interruption, maximizing throughput while maintaining high enantiomeric purity in the final product

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process enables the efficient preparation of fluoroleucine alkyl esters with high enantiomeric excess and chiral purity, overcoming the challenges of asymmetric synthesis and providing a viable route for pharmaceutical applications.

Implementation Method 1

a. alkylating an imine carboxylate of formula IIA with methallyl halide to form a substituted imine of formula IIIA

Methodology Applied
Scientific EffectAlkylation: Chemical Bonding

Implementation Method 2

b. deprotecting the substituted imine of formula IIIA with an acid to yield an amine of formula IVA

Methodology Applied
Scientific EffectDeprotection: Chemical Bonding

Implementation Method 3

c. resolving the amine of formula IVA with a chiral protic acid selected from the group consisting of D-(+)-camphor-10-sulfonic acid, D-BOC-proline, di-p-tolyl-D-tartaric acid, N-acetyl-D-phenyl alanine and mixtures thereof

Methodology Applied
Scientific EffectResolution: Crystallisation

Implementation Method 4

d. fluorinating the resolved amine to yield the compound of formula IA

Methodology Applied
Scientific EffectFluorination: Chemical Bonding

Data Source

PatentEP2831036B1Process for preparing fluoroleucine alkyl esters
Publication Date: 2018.09.12 INTERVET INT BV
  • EP2831036B1 patent drawing
  • EP2831036B1 patent drawing
  • EP2831036B1 patent drawing

AI summary

This invention relates to a resolution process for the preparation of fluoroleucine alkyl esters.